Zacks.com on MSN7mon
Pacira (PCRX) Plummets as US Court Deems Exparel Patent InvalidPacira BioSciences’ PCRX shares plunged 47.7% on Aug 9, after the U.S. District Court for the District of New Jersey ruled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback